{
  "id": 4936920,
  "title": "Mounjaro's Label Expands; Type 1 Diabetes on the Rise; Testosterone and Afib",
  "url": "https://urgent.news/2026/09/01/mounjaros-label-expands-type-1-diabetes-on-the-rise-testosterone-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-01T19:19:14.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/endocrinology/generalendocrinology/122850"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA expanded the indication for tirzepatide (Mounjaro) to include reducing the risk of major adverse cardiovascular events in high-risk adults with type 2 diabetes, Eli Lilly announced. Global type 1 diabetes prevalence...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}